Lunit said it signed a collaboration agreement with the Abu Dhabi Health Services Company (SEHA) to test its artificial intelligence (AI)-based radiology software in the Middle East. 

Lunit CBO Jang Min-hong (third from left) and Dr. Afra Rashed Saeed Almesaied Alneyadi (center) pose for a photo after signing the cooperation agreement to test Lunit’s AI-based radiology systems in UAE.
Lunit CBO Jang Min-hong (third from left) and Dr. Afra Rashed Saeed Almesaied Alneyadi (center) pose for a photo after signing the cooperation agreement to test Lunit’s AI-based radiology systems in UAE.

Under the accord, Lunit and SEHA will proceed with a proof of concept (POC) of the Lunit INSIGHT CXR, an AI solution for chest X-ray analysis, and the Lunit INSIGHT MMG, an AI solution for mammography analysis, for evaluation at medical institutions across the Middle East.

According to Lunit, SEHA is a comprehensive healthcare network under the UAE’s largest healthcare provider Pure Health. Established in 2007, SEHA currently operates 14 hospitals and primary healthcare clinics with a total of more than 3,000 beds.

“Lunit entered the Middle Eastern market following its supply contract with Roche and Microsoft Azure in March to export Lunit INSIGHT MMG,” Lunit CEO Suh Beom-seok said. “Through this exciting collaboration with SEHA, we expect to further expand our business in the Middle East.”

Dr. Afra Rashed Saeed Almesaied Alneyadi, a radiologist at SEHA, also said, “Through this contract, we will work with Lunit to implement Korea’s world-class medical AI imaging solution during the POC experiments.” Alneyadi added.

According to Data Bridge Market Research, the medical imaging market in the Middle East, which surpassed $20 billion in 2021, is projected to exceed $30 billion by 2029, with an expected average annual growth of 5.5 percent from 2022 to 2029.

Copyright © KBR Unauthorized reproduction, redistribution prohibited